| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |